Financial Performance - Total revenues for Q3 2025 were $17.361 billion, a decrease of 1.1% compared to Q3 2024's $18.440 billion[4] - Net income attributable to MetLife, Inc. for Q3 2025 was $896 million, reflecting a decrease of 29.5% from $1.271 billion in Q3 2024[4] - Premiums, fees, and other revenues for Q3 2025 totaled $12.526 billion, down 0.2% from $12.523 billion in Q3 2024[4] - Policyholder benefits and claims for Q3 2025 were $10.369 billion, a decrease of 17.3% from $12.572 billion in Q3 2024[4] - Net investment income for Q3 2025 was $6.089 billion, an increase of 12.5% compared to $5.405 billion in Q3 2024[4] - Total expenses for Q3 2025 were $16.151 billion, a decrease of 6.6% from $17.285 billion in Q3 2024[4] - Adjusted earnings available to common shareholders for Q3 2025 were $2.987 billion, compared to $2.395 billion in Q3 2024[4] - Total adjusted revenues for the three months ended September 30, 2024, were $17,614 million, compared to $19,738 million for the same period in 2024, reflecting a decrease of 10.7%[11] - Total adjusted revenues for the year-to-date period ended September 30, 2025, were $54,649 million, up from $53,313 million in 2024, indicating a growth of 2.5%[11] Investment Performance - The company reported net derivative gains of $929 million in Q3 2025, compared to losses of $903 million in Q3 2024[4] - Net investment income for the year-to-date period ended September 30, 2025, was $16,635 million, up from $15,868 million in the previous year, representing an increase of 4.8%[11] - Adjusted net investment income for the three months ended September 30, 2025, was $5,440 million, an increase from $5,213 million in the previous year, reflecting a growth of 4.4%[11] - The company reported variable investment income of $720 million for the year-to-date period ended September 30, 2025, compared to $1,005 million in the previous year, reflecting a decrease of 28.5%[11] - The company reported a net investment gain of $(325) million for the three months ended September 30, 2025, compared to $(77) million for the same period in 2024, indicating a worsening performance[60] Tax and Provision Expenses - The provision for income tax expense in Q3 2025 was $308 million, compared to $106 million in Q3 2024[4] - The total provision for income tax expense increased to $531 million for the third quarter of 2025, up from $458 million in the same quarter of 2024, indicating a rise of 15.9%[20] Shareholder Metrics - Adjusted earnings available to common shareholders reached $1,584 million for the three months ended September 30, 2025, representing an increase of 16.3% compared to $1,375 million in the same period of 2024[20] - The total equity of MetLife, Inc. increased to $29,191 million as of September 30, 2025, compared to $31,164 million at the end of 2024, reflecting a decrease of approximately 6.3%[19] - Book value per common share increased to $39.02 in Q3 2024 from $34.28 in Q4 2024[8] - Adjusted return on common stockholders' equity was 14.6% in Q3 2024, up from 14.4% in Q4 2024[8] - Common shares outstanding decreased to 693.7 million at the end of Q3 2024 from 689.2 million in Q4 2024, reflecting share repurchases[8] Segment Performance - The Group Benefits segment reported adjusted earnings of $455 million for the third quarter of 2025, an increase of 21.9% from $373 million in the same quarter of 2024[20] - The Asia segment's adjusted earnings surged to $543 million in the third quarter of 2025, a significant increase of 77.8% compared to $306 million in the same quarter of 2024[20] - The Corporate & Other segment reported adjusted losses of $288 million for the third quarter of 2025, widening from a loss of $249 million in the same quarter of 2024[20] Asset and Liability Management - Total assets increased to $719,726 million as of September 30, 2025, up from $704,976 million at the end of 2024, reflecting a growth of approximately 2.6%[19] - Total liabilities rose to $690,535 million as of September 30, 2025, compared to $673,812 million at the end of 2024, marking an increase of approximately 2.5%[19] - Cash and cash equivalents decreased to $20,233 million as of September 30, 2025, down from $21,765 million at the end of 2024, reflecting a decline of about 7.1%[19] Notable Items and Adjustments - Total notable items impacting adjusted earnings available to common shareholders were $16 million in Q3 2024, compared to $10 million in Q4 2024[6] - The total notable items for the year-to-date period ended September 30, 2025, amounted to $18 million, reflecting adjustments from various unexpected events[65] - MetLife's total notable items for Q3 2024 included $16 million from actuarial assumption reviews and other insurance adjustments[65] Operational Efficiency - The expense ratio for the three months ended September 30, 2024, was 17.8%, which increased to 21.7% for the three months ended June 30, 2025[17] - Adjusted other expenses for the year-to-date period ended September 30, 2025, were $9,860 million, compared to $9,443 million in 2024, representing an increase of 4.4%[15] - The adjusted expense ratio for the three months ended September 30, 2024, was 19.8%, which rose to 20.6% for the three months ended September 30, 2025[18]

Core Insights - MetLife reported strong third quarter results for 2025, showcasing the effectiveness of its diversified business model and strategic initiatives [2][4][3] Financial Performance - Net income for 3Q 2025 was $818 million, or $1.22 per share, a decrease of 36% year-over-year [12][5] - Adjusted earnings increased by 15% to $1.6 billion, with adjusted earnings per share rising 22% to $2.37 [12][5] - Premiums, fees, and other revenues were $12.5 billion, flat compared to the prior year, but adjusted revenues excluding pension risk transfers grew by 4% [9][6] - Net investment income rose 16% to $6.1 billion, driven by higher returns on private equity assets [10][5] Segment Performance - Group Benefits adjusted earnings were $455 million, up 22%, while adjusted premiums and fees increased by 3% to $6.3 billion [20][17] - Retirement and Income Solutions (RIS) adjusted earnings decreased by 8% to $436 million, with adjusted premiums and fees down 25% [21][18] - Asia segment saw adjusted earnings surge by 77% to $543 million, with sales up 34% on a constant currency basis [25][19] - Latin America adjusted earnings fell by 33% to $147 million, impacted by a tax charge, but adjusted premiums and fees rose by 11% [26][22] - EMEA adjusted earnings increased by 26% to $88 million, reflecting strong volume growth [27][23] Strategic Initiatives - The company secured $12 billion in pension risk transfer mandates in the fourth quarter to date, indicating strong momentum [3][5] - MetLife expanded its Xcelerator program in Latin America through a partnership with Mercado Libre, enhancing its market reach [5][5] Shareholder Returns - Approximately $875 million was returned to shareholders through share repurchases and dividends [5][5] - Book value per share increased by 1% to $39.52, while adjusted book value per share rose by 3% to $56.57 [5][6]

Core Insights - MetLife, Inc. has released a financial update for the third quarter of 2025, presented by CFO John McCallion [1][8] - The company reported a net income of $818 million, translating to earnings per share of $1.22, with adjusted earnings increasing by 15% to $1.6 billion [8] Financial Performance - Net income for Q3 2025 was $818 million, or $1.22 per share [8] - Adjusted earnings rose by 15% to $1.6 billion, driven by higher variable investment income and volume growth [8] - Adjusted earnings per share, excluding notable items, increased by 21% [8] - Return on Equity (ROE) was reported at 13.1%, while adjusted ROE was 16.9% [8] Company Overview - MetLife, Inc. is a leading financial services company providing insurance, annuities, employee benefits, and asset management [2] - The company operates in over 40 markets globally and has a strong presence in the U.S., Asia, Latin America, Europe, and the Middle East [2]

Core Viewpoint - MetLife Inc. is expected to report strong quarterly earnings with significant year-over-year growth in EPS and revenue, despite facing some challenges in specific segments [1][2][3]. Financial Performance Expectations - Analysts estimate an EPS of $2.31 for the upcoming quarterly earnings, with a projected revenue of $18.64 billion [1][6]. - The Zacks Consensus Estimate predicts an EPS of $2.33, reflecting a 20.7% increase from the previous year, driven by higher premiums and strong international operations [2][6]. - Revenue is expected to reach $18.8 billion, indicating a 7% year-over-year growth [2]. Challenges and Analyst Sentiment - MetLife faces challenges such as rising costs and weaker results in its Retirement and Income Solutions segment, which may temper profit gains [3]. - Despite these challenges, the earnings estimate has improved over the past month, indicating positive sentiment among analysts [3][6]. Valuation Metrics - The company has a price-to-earnings (P/E) ratio of approximately 12.43, suggesting the price investors are willing to pay for each dollar of earnings [4]. - The price-to-sales ratio is about 0.72, indicating that investors pay 72 cents for every dollar of sales [4]. - The enterprise value to sales ratio is around 0.69, reflecting MetLife's valuation compared to its sales [5]. - The enterprise value to operating cash flow ratio is approximately 3.21, indicating how well the company can cover its enterprise value with its operating cash flow [5]. - The earnings yield is about 8.04%, providing insight into the return on investment for shareholders [5].

Core Insights - MetLife, Inc. is scheduled to report its third-quarter 2025 results on November 5, with earnings estimated at $2.33 per share and revenues at $18.8 billion, reflecting a year-over-year growth of 20.7% and 7% respectively [1][6] Financial Performance - The Zacks Consensus Estimate for MetLife's total revenues for the current year is $74.6 billion, indicating a 2.1% increase year-over-year, while the EPS estimate stands at $8.69, suggesting a 7.2% rise [2] - MetLife has missed earnings consensus estimates in each of the last four quarters [2] Earnings Predictions - The current model does not predict an earnings beat for MetLife, with an Earnings ESP of -0.23% and a Zacks Rank of 3 (Hold) [3] - The expected revenue growth in Q3 is attributed to rising premiums and adjusted group benefits revenues, particularly in international markets such as Asia, EMEA, and Latin America, with a projected 7.2% increase in premiums year-over-year [4][5] Revenue Drivers - The adjusted group benefits revenue is expected to rise by 2.8% year-over-year, with significant contributions from improved profits in Asia and Latin America [5] - The Latin America segment is anticipated to show a 10.6% year-over-year growth in adjusted earnings [7] Cost Considerations - Rising costs and weaker results from the Retirement and Income Solutions segment may limit profit gains, with a projected 13% decline in adjusted earnings from this segment year-over-year [8]

Core Insights - Wall Street analysts anticipate MetLife (MET) will report quarterly earnings of $2.33 per share, reflecting a year-over-year increase of 20.7% [1] - Expected revenues for the quarter are projected at $18.84 billion, which represents a 7% increase from the same quarter last year [1] - Over the past 30 days, the consensus EPS estimate has been revised upward by 0.8%, indicating a reassessment of forecasts by analysts [1] Revenue Estimates - The consensus estimate for 'Revenue- Premiums' is $11.41 billion, indicating a year-over-year change of +7.2% [4] - 'Revenue- Other Revenues' is estimated at $653.32 million, reflecting a change of +0.8% from the prior-year quarter [4] - 'Revenue- Universal life and investment-type product policy fees' is projected to be $1.31 billion, showing a year-over-year change of +6.5% [4] Investment Income and Adjusted Revenue - Analysts forecast 'Revenue- Net investment income' to reach $5.47 billion, indicating a year-over-year change of +4.7% [5] - 'Total Adjusted Revenue- Latin America' is expected to be $2.09 billion, reflecting an increase of +8.4% year over year [5] - 'Adjusted Revenue- Corporate & other- Net investment income' is projected at $83.06 million, indicating a decrease of -13.5% from the year-ago quarter [5] Regional Revenue Projections - 'Total Adjusted Revenue- EMEA' is expected to reach $773.03 million, indicating a change of +8.9% from the prior-year quarter [6] - 'Total Adjusted Revenue- Asia' is projected at $3.08 billion, reflecting a year-over-year change of +8.5% [6] - 'Adjusted Revenue- Asia- Net investment income' is anticipated to be $1.31 billion, indicating a change of +15.5% from the prior-year quarter [6] Additional Revenue Insights - 'Adjusted Revenue- EMEA- Net investment income' is expected to be $62.02 million, reflecting a year-over-year change of +12.8% [7] - 'Adjusted Revenue- Latin America- Net investment income' is projected at $442.90 million, indicating a change of +1.8% from the year-ago quarter [7] - 'Adjusted Revenue- Asia- Other Revenues' is estimated at $20.48 million, suggesting a year-over-year change of +13.8% [8] Stock Performance - MetLife shares have shown a return of -2.7% over the past month, contrasting with the Zacks S&P 500 composite's +2.1% change [8] - The company holds a Zacks Rank 3 (Hold), indicating expectations to mirror overall market performance in the near future [8]

Let's get back to the broader markets and the outlook for the economy after consumer confidence this month did fall to the lowest level since April. Joining us this morning is Medlife Investment Management chief market strategist Drew Mattis. Been watching a lot of this stuff closely.Drew, good to see you again. >> Good to good to be here. So, Conference Board is is kind of instructive and it it does fit a little bit with the narrative being built at Amazon and GM and Paramount uh where headcount is either ...

Company Overview - The company was established as a spin-off from MetLife in 2017 and is now recognized as a significant player in the annuity and life insurance sector [1] Analyst Profile - Chad Shoop, a Chartered Market Technician (CMT) since 2016, has developed three premium investment services focused on options trading [2] - Over the past decade, Chad has been a prominent presenter at Banyan Hill's annual Total Wealth Symposium, where he shares insights on income opportunities and his investment services [2] - Chad utilizes technical analysis across the stock market to identify profitable investment opportunities and make reliable market predictions [2] - He holds two bachelor's degrees in economics and finance from the University of North Carolina at Greensboro [2] - Chad emphasizes the importance of extensive research, back testing, and beta testing in helping others grow their wealth and become financially knowledgeable [2]

Core Insights - MetLife, Inc. has partnered with Empathy to launch Leave Support, a digital platform aimed at assisting employees during their leave of absence from work [1][9] - Leave Support will be exclusively available through MetLife later this year, guiding employees through the leave process and their transition back to work [2] - The platform enhances MetLife's existing My Leave Navigator solution, providing personalized tools, expert guidance, and resources to improve employee well-being and simplify claims [3] Industry Context - The initiative addresses the growing need for support as many employees take time off for health-related reasons, which can complicate their recovery and return to work [4] - Providing effective support during leave can lead to quicker recovery and a more confident return to work, positioning MetLife to capitalize on this demand [5] Business Impact - The launch of Leave Support reflects MetLife's commitment to enhancing its disability and leave solutions, strengthening its relationship with Empathy, which began with the introduction of Loss Support in 2022 [6] - Integrating Leave Support into its offerings is expected to attract more customers to MetLife's insurance policies, potentially increasing premium revenues, which rose by 3.4% year over year in the first half of 2025 [7] Stock Performance - MetLife's shares have increased by 12.5% over the past six months, outperforming the industry average growth of 9.3% [8]

want to get his take on the markets, treasuries, the economy amid this government shutdown. I want to bring in Drew Mattis. He's the chief market strategist at Metife Investment Management.Uh we keep uh we keep moving higher. Are we moving too high or you know, you can only get higher if you go higher. So where are we.>> Well, I think that's a great point. When you compare what earnings expectations are and you compare it to growth expectations among economists, you know, there's a gap there. uh and if you' ...